Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades

We aimed to assess SSc mortality by age in the general population over the past five decades. This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology (Oxford, England) England), 2024-02, Vol.63 (2), p.466-471
Hauptverfasser: Yen, Eric Y, Singh, Devanshu R, Singh, Ram Raj
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 471
container_issue 2
container_start_page 466
container_title Rheumatology (Oxford, England)
container_volume 63
creator Yen, Eric Y
Singh, Devanshu R
Singh, Ram Raj
description We aimed to assess SSc mortality by age in the general population over the past five decades. This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters. SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)]. Mortality for SSc has steadily decreased at younger ages over the past five decades.
doi_str_mv 10.1093/rheumatology/kead233
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10836968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2818055205</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-911906b59ae99d36de7acbc8f344d8673d63cafe34ab2e54380328b9665d7fc93</originalsourceid><addsrcrecordid>eNpVUU1v1DAQtRCIlsI_QMhHLkttT-K1TwhV5UOqxAE4m4k92TUk8WI7K-Xfk6rLqpzmjWbem4_H2Gsp3klh4TrvaR6xpiHtluvfhEEBPGGXstFqIwDU0zNWzQV7UcovIUQrwTxnF7BVUhtrLtnPb3WlLjyQz4SFeJx4WUqlMXpe_EA5lVj4mHLFIdaFZ6xUOFa-pHnaUea4W_N0XFHdEz9gqbyPR7pXxEDlJXvW41Do1SlesR8fb7_ffN7cff305ebD3caDVHVjpbRCd61FsjaADrRF33nTQ9MEo7cQNHjsCRrsFLUNmPUu01mt27DtvYUr9v5B9zB3IwVPU804uEOOI-bFJYzu_8oU926Xjk4KA9pqsyq8PSnk9GemUt0Yi6dhwInSXJwy0oi2VaJdW5uHVr--p2Tqz3OkcPfuuMfuuJM7K-3N4x3PpH92wF8LxJOJ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2818055205</pqid></control><display><type>article</type><title>Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Yen, Eric Y ; Singh, Devanshu R ; Singh, Ram Raj</creator><creatorcontrib>Yen, Eric Y ; Singh, Devanshu R ; Singh, Ram Raj</creatorcontrib><description>We aimed to assess SSc mortality by age in the general population over the past five decades. This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters. SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)]. Mortality for SSc has steadily decreased at younger ages over the past five decades.</description><identifier>ISSN: 1462-0324</identifier><identifier>ISSN: 1462-0332</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kead233</identifier><identifier>PMID: 37216898</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Clinical Science ; Databases, Factual ; Humans ; Mortality ; Risk Factors ; Scleroderma, Systemic</subject><ispartof>Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.466-471</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.</rights><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c312t-911906b59ae99d36de7acbc8f344d8673d63cafe34ab2e54380328b9665d7fc93</cites><orcidid>0000-0002-6831-4538</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37216898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yen, Eric Y</creatorcontrib><creatorcontrib>Singh, Devanshu R</creatorcontrib><creatorcontrib>Singh, Ram Raj</creatorcontrib><title>Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><description>We aimed to assess SSc mortality by age in the general population over the past five decades. This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters. SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)]. Mortality for SSc has steadily decreased at younger ages over the past five decades.</description><subject>Clinical Science</subject><subject>Databases, Factual</subject><subject>Humans</subject><subject>Mortality</subject><subject>Risk Factors</subject><subject>Scleroderma, Systemic</subject><issn>1462-0324</issn><issn>1462-0332</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1v1DAQtRCIlsI_QMhHLkttT-K1TwhV5UOqxAE4m4k92TUk8WI7K-Xfk6rLqpzmjWbem4_H2Gsp3klh4TrvaR6xpiHtluvfhEEBPGGXstFqIwDU0zNWzQV7UcovIUQrwTxnF7BVUhtrLtnPb3WlLjyQz4SFeJx4WUqlMXpe_EA5lVj4mHLFIdaFZ6xUOFa-pHnaUea4W_N0XFHdEz9gqbyPR7pXxEDlJXvW41Do1SlesR8fb7_ffN7cff305ebD3caDVHVjpbRCd61FsjaADrRF33nTQ9MEo7cQNHjsCRrsFLUNmPUu01mt27DtvYUr9v5B9zB3IwVPU804uEOOI-bFJYzu_8oU926Xjk4KA9pqsyq8PSnk9GemUt0Yi6dhwInSXJwy0oi2VaJdW5uHVr--p2Tqz3OkcPfuuMfuuJM7K-3N4x3PpH92wF8LxJOJ</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Yen, Eric Y</creator><creator>Singh, Devanshu R</creator><creator>Singh, Ram Raj</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6831-4538</orcidid></search><sort><creationdate>20240201</creationdate><title>Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades</title><author>Yen, Eric Y ; Singh, Devanshu R ; Singh, Ram Raj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-911906b59ae99d36de7acbc8f344d8673d63cafe34ab2e54380328b9665d7fc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Clinical Science</topic><topic>Databases, Factual</topic><topic>Humans</topic><topic>Mortality</topic><topic>Risk Factors</topic><topic>Scleroderma, Systemic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yen, Eric Y</creatorcontrib><creatorcontrib>Singh, Devanshu R</creatorcontrib><creatorcontrib>Singh, Ram Raj</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yen, Eric Y</au><au>Singh, Devanshu R</au><au>Singh, Ram Raj</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>63</volume><issue>2</issue><spage>466</spage><epage>471</epage><pages>466-471</pages><issn>1462-0324</issn><issn>1462-0332</issn><eissn>1462-0332</eissn><abstract>We aimed to assess SSc mortality by age in the general population over the past five decades. This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters. SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)]. Mortality for SSc has steadily decreased at younger ages over the past five decades.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>37216898</pmid><doi>10.1093/rheumatology/kead233</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-6831-4538</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.466-471
issn 1462-0324
1462-0332
1462-0332
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10836968
source MEDLINE; Oxford University Press Journals All Titles (1996-Current)
subjects Clinical Science
Databases, Factual
Humans
Mortality
Risk Factors
Scleroderma, Systemic
title Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A16%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Steady%20decrease%20in%20systemic%20sclerosis%20mortality%20rates%20at%20younger%20ages%20over%20the%20past%20five%20decades&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Yen,%20Eric%20Y&rft.date=2024-02-01&rft.volume=63&rft.issue=2&rft.spage=466&rft.epage=471&rft.pages=466-471&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kead233&rft_dat=%3Cproquest_pubme%3E2818055205%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2818055205&rft_id=info:pmid/37216898&rfr_iscdi=true